Narrative Inquiry on the Innovation Journeys of Biomedical and Health Technology Startup Founders in the Philippines

Abstract Purpose Research on biomedical and health technology startups in the Philippines has documented regulatory, financial, and market barriers, but little is known about how founders themselves experience, interpret, and manage the journey from ideation to commercialization. This study examines how biomedical and health technology startup founders narrate that journey in the Philippines, a resource-constrained, lower-middle-income country. Methodology: Guided by a constructivist-interpretivist paradigm, the study used narrative inquiry with eight purposively selected founders representing medical devices, pharmaceuticals, diagnostics, and digital health. The study conducted semi-structured narrative interviews, re-storied them into individual narrative profiles, member-checked them, manually coded them, and compared them through cross-narrative synthesis, retaining negative cases. Findings: The journeys were organized around five non-linear narrative thresholds: arrival or entry; building and validation under constraint; regulatory qualification; procurement and adoption; and relational reconfiguration with the systemic environment as well as, resilience and identity reconstruction. Entry was relational and often serendipitous. A problem-led orientation and commitment to identifiable beneficiaries sustained the founders. Founders validated functioning technologies through improvisation and resource combination. Regulatory qualification varied by product and venture. Founders sought clear product categorization, proportionate requirements, and predictable timelines rather than deregulation. The sharpest divergence occurred after validation, when procurement and institutional adoption enabled movement or produced delays, redirection, withdrawal, or re-entry. Financing and adoption were mutually constraining. Resilience and narrative identity formed an adaptive architecture. Resilience was characterized as individualized, team-distributed, or organizational, while identity was reconstructed in sequential, layered accumulation or continuity deepening modes. Implications: The study qualifies effectuation, resilience, narrative identity, and diffusion of innovations for resource-constrained biomedical settings. For policy, it points to aligning development funding with public procurement, proportionate regulatory pathways, pre-revenue financing, simplified administrative processes, and entrepreneurial capability building. Originality/Value: This is among the first founder-centered narrative studies of biomedical and health technology commercialization in the Philippines. It shows that the decisive challenge is not invention itself but moving viable technologies into institutional adoption and sustained public benefit. JEL codes: L26, O31, O32, I11, I18, O53.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11647366/v1
Primary Topic
Entrepreneurship Studies and Influences
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Narrative Inquiry on the Innovation Journeys of Biomedical and Health Technology Startup Founders in the Philippines

Leo Mendel D. Rosario, Christina Marquez
Research Square
Entrepreneurship Studies and Influences
preprint

Narrative Inquiry on the Innovation Journeys of Biomedical and Health Technology Startup Founders in the Philippines

Leo Mendel D. Rosario, Christina Marquez
preprint en

Abstract

Abstract Purpose Research on biomedical and health technology startups in the Philippines has documented regulatory, financial, and market barriers, but little is known about how founders themselves experience, interpret, and manage the journey from ideation to commercialization. This study examines how biomedical and health technology startup founders narrate that journey in the Philippines, a resource-constrained, lower-middle-income country. Methodology: Guided by a constructivist-interpretivist paradigm, the study used narrative inquiry with eight purposively selected founders representing medical devices, pharmaceuticals, diagnostics, and digital health. The study conducted semi-structured narrative interviews, re-storied them into individual narrative profiles, member-checked them, manually coded them, and compared them through cross-narrative synthesis, retaining negative cases. Findings: The journeys were organized around five non-linear narrative thresholds: arrival or entry; building and validation under constraint; regulatory qualification; procurement and adoption; and relational reconfiguration with the systemic environment as well as, resilience and identity reconstruction. Entry was relational and often serendipitous. A problem-led orientation and commitment to identifiable beneficiaries sustained the founders. Founders validated functioning technologies through improvisation and resource combination. Regulatory qualification varied by product and venture. Founders sought clear product categorization, proportionate requirements, and predictable timelines rather than deregulation. The sharpest divergence occurred after validation, when procurement and institutional adoption enabled movement or produced delays, redirection, withdrawal, or re-entry. Financing and adoption were mutually constraining. Resilience and narrative identity formed an adaptive architecture. Resilience was characterized as individualized, team-distributed, or organizational, while identity was reconstructed in sequential, layered accumulation or continuity deepening modes. Implications: The study qualifies effectuation, resilience, narrative identity, and diffusion of innovations for resource-constrained biomedical settings. For policy, it points to aligning development funding with public procurement, proportionate regulatory pathways, pre-revenue financing, simplified administrative processes, and entrepreneurial capability building. Originality/Value: This is among the first founder-centered narrative studies of biomedical and health technology commercialization in the Philippines. It shows that the decisive challenge is not invention itself but moving viable technologies into institutional adoption and sustained public benefit. JEL codes: L26, O31, O32, I11, I18, O53.

Research Square
University of the Philippines Open University (PH)
Good health and well-being, Industry, innovation and infrastructure, Decent work and economic growth
Entrepreneurship Studies and Influences
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon